Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is double autologous stem-cell transplantation appropriate for new multiple myeloma patients?

Nature Clinical Practice Oncology volume 5, pages 70–71 (2008)Cite this article

boxed-textCavo M et al. (2007) Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study. J Clin Oncol 25: 2434–2441

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Pui CH and Evans WE (2006) Drug therapy: treatment of acute lymphoblastic leukemia. N Engl J Med 354: 166–178

    Article  CAS  Google Scholar 

  2. Attal M et al. (2003) Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med 349: 2495–2502

    Article  CAS  Google Scholar 

  3. Abdelkefi A et al. (2007) Single autologous stem cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma: results of a multicenter randomized clinical trial. Blood [doi:10.1182/blood-2007-07-101212]

  4. Shaughnessy JD Jr et al. (2007) A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1. Blood 109: 2276–2284

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, 4301 West Markham, Little Rock, AR 72205, USA vanrheefrits@uams.edu

Authors and Affiliations

  1. F van Rhee is Director of Clinical Research at the Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.,

    Frits van Rhee

Authors
  1. Frits van Rhee
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

van Rhee, F. Is double autologous stem-cell transplantation appropriate for new multiple myeloma patients?. Nat Rev Clin Oncol 5, 70–71 (2008). https://doi.org/10.1038/ncponc1005

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc1005

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing